Antibody Induced Neutrophil Tissue Pathology in Renal Allografts
Antibody Induced Neutrophil Tissue Pathology in Renal Allografts
批准号:
7891948
负责人:
Robert L Fairchild
金额:
$32.89万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-08 至 2015-05-31
关键词:
AcuteAllograftingAnimal ModelAnimalsAntibodiesAntibody FormationAntibody RepertoireAntigen TargetingAttenuatedB-LymphocytesBindingBlood capillariesCCR5 geneCellsChemotactic FactorsChronicClinicalComplement 3dDepositionDevelopmentDonor personEdemaEndotheliumEventFibrosisFunctional disorderGoalsGraft RejectionHistopathologyImmunosuppressionIncidenceInfiltrationInflammationInflammatoryInjuryInstructionKidneyKidney TransplantationLifeMediatingModelingMyocardiumNeutrophil ActivationNeutrophil InfiltrationOutcomePathologyPathway interactionsPopulationProcessProductionRegimenReportingRoleSerumStudy modelsT-LymphocyteTestingTissue GraftsTissuesTransplantationallograft rejectionbasecapillarygraft failureheart allograftinsightinterstitialkidney allograftmacrophagemouse modelneutrophilnovelpreventresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Antibody mediated mechanisms leading to graft injury and loss remain pooriy understood. Investigafion into
these mechanisms is hampared by the lack of appropriate animal models to study the development of
allograft injury as the donor-specific antibody response is initiated and increases. For the most part, models
studying acute humoral rejection use either transfer of graft-reactive antibodies or sensitization of recipients
with donor cells which also primes donor-reactive T cell populations. We have recently reported a novel
model of antibody-meidated rejection of renal allografts in CCR5-/- recipients where the titers of donorspecific
anfibody in CCR5-deficient recipients were almost 20-fold higher than in wild-type recipients and
graft rejection was characterisfic of acute humoral rejecfion observed in clinical transplants. In CCR5-
deficient animals, the renal allografts are rejected between days 10 and 20 with heavy deposition of C3d,
peritubular edema and neutrophil infiltrafion. These and our preliminary results have led us to propose the
hypothesis that a key mechanims underlying antibody-mediated rejection of renal allografts is the induced
infiltration and activation of neutrophils in the grafts which directly causes graft tissue injury and increases
the target antigens of the recipient antibody response. This hypothesis will be tested in three specific aims.
In Specific Aim 1 we will directly test the role of neutrophils in the graft fissue pathology inflated by specifc
antibodies in the rejecfion of renal allografts of varying MHC disparities in the CCR5-/- recipients. In Specific
Aim 2 we will test the role of this neutrophil mediated fissue damage on the repertoire of anfibodies induced
to renal allografts of varying MHC disparities. In the final specific aim we will use a B cell depletion strategy
to test the effect of limiting donor-specific antibody interaction with the renal allograft on the development of
acute tissue injury as well as on the development of interstitital fibrosis, pathologies that impact the
immediate function and longterm outcome of renal allograft survival. These studies will provide novel
insights into mechanisms underlying the pathologies induced following donor-reactive anfibody binding to the
allograft endothelium.
RELEVANCE (See instructions):
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies
-
批准号:10734277
-
项目类别:
-
资助金额:$72.34万
-
财政年份:2023
-
负责人:Robert L Fairchild
-
依托单位:
Post-transcriptional regulation of gene expression by microRNAs in antibody-mediated rejection
-
批准号:10522285
-
项目类别:
-
资助金额:$70.11万
-
财政年份:2022
-
负责人:Robert L Fairchild
-
依托单位:
Chronic Antibody-Mediated Rejection of Kidney Allografts
-
批准号:10416460
-
项目类别:
-
资助金额:$64.64万
-
财政年份:2022
-
负责人:Robert L Fairchild
-
依托单位:
Post-transcriptional regulation of gene expression by microRNAs in antibody-mediated rejection
-
批准号:10693399
-
项目类别:
-
资助金额:$65.96万
-
财政年份:2022
-
负责人:Robert L Fairchild
-
依托单位:
Chronic Antibody-Mediated Rejection of Kidney Allografts
-
批准号:10557880
-
项目类别:
-
资助金额:$64.64万
-
财政年份:2022
-
负责人:Robert L Fairchild
-
依托单位:
Post-transcriptional regulation of gene expression by microRNAs in antibody-mediated rejection.
-
批准号:10475333
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2021
-
负责人:Robert L Fairchild
-
依托单位:
Acute Antibody Mediated Kidney Allograft Rejection
-
批准号:10490876
-
项目类别:
-
资助金额:$60.75万
-
财政年份:2021
-
负责人:Robert L Fairchild
-
依托单位:
Acute Antibody Mediated Kidney Allograft Rejection
-
批准号:10362234
-
项目类别:
-
资助金额:$60.75万
-
财政年份:2021
-
负责人:Robert L Fairchild
-
依托单位:
Acute Antibody Mediated Kidney Allograft Rejection
-
批准号:10683315
-
项目类别:
-
资助金额:$60.75万
-
财政年份:2021
-
负责人:Robert L Fairchild
-
依托单位:
Antibody induced neutrophil and macrophage tissue pathology in renal allografts
-
批准号:9086202
-
项目类别:
-
资助金额:$38.23万
-
财政年份:2016
-
负责人:Robert L Fairchild
-
依托单位:
Antibody-Mediated Rejection of Renal Allografts
-
批准号:8932396
-
项目类别:
-
资助金额:$181.56万
-
财政年份:2010
-
负责人:Robert L Fairchild
-
依托单位:
Administrative
-
批准号:7891955
-
项目类别:
-
资助金额:$14.31万
-
财政年份:2010
-
负责人:Robert L Fairchild
-
依托单位:
Acute Humoral Rejection of Renal Allografts
-
批准号:8081805
-
项目类别:
-
资助金额:$162.26万
-
财政年份:2010
-
负责人:Robert L Fairchild
-
依托单位:
Acute Humoral Rejection of Renal Allografts
-
批准号:8470532
-
项目类别:
-
资助金额:$152.46万
-
财政年份:2010
-
负责人:Robert L Fairchild
-
依托单位:
Surgery Core
-
批准号:9283286
-
项目类别:
-
资助金额:$29.96万
-
财政年份:2010
-
负责人:Robert L Fairchild
-
依托单位:
Acute Humoral Rejection of Renal Allografts
-
批准号:8664779
-
项目类别:
-
资助金额:$162.2万
-
财政年份:2010
-
负责人:Robert L Fairchild
-
依托单位:
Antibody-Mediated Rejection of Renal Allografts
-
批准号:9086197
-
项目类别:
-
资助金额:$193.45万
-
财政年份:2010
-
负责人:Robert L Fairchild
-
依托单位:
Acute Humoral Rejection of Renal Allografts
-
批准号:8274792
-
项目类别:
-
资助金额:$162.2万
-
财政年份:2010
-
负责人:Robert L Fairchild
-
依托单位:
Acute Humoral Rejection of Renal Allografts
-
批准号:7853665
-
项目类别:
-
资助金额:$162.68万
-
财政年份:2010
-
负责人:Robert L Fairchild
-
依托单位:
Surgery
-
批准号:7891956
-
项目类别:
-
资助金额:$23.75万
-
财政年份:2010
-
负责人:Robert L Fairchild
-
依托单位:
海外基金